Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
Loading
Debt to Assets Over TimeNormalizing
Percentile Rank71
3Y CAGR-11.6%
5Y CAGR+11.0%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-11.6%/yr
vs +110.3%/yr prior
5Y CAGR
+11.0%/yr
Recent deceleration
Acceleration
-121.8pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.26 | -60.2% |
| 2024 | 0.65 | +89.8% |
| 2023 | 0.34 | -8.4% |
| 2022 | 0.37 | +36.0% |
| 2021 | 0.27 | +79.0% |
| 2020 | 0.15 | +20.6% |
| 2019 | 0.13 | +565.9% |
| 2018 | 0.02 | +26.7% |
| 2017 | 0.02 | -87.3% |
| 2016 | 0.12 | - |